Goodwin Technology and Life Sciences partner David Mardle shares what he sees as the biggest challenges facing life science SMEs at the moment, current and future investor behavior in the financing and M&A environment, and the new digital norm and legal processes companies must consider during this unprecedented time. Read the Q&A in LSX here.
Related Content
- Big Molecule WatchSeptember 26, 2023
Update on Recent International Biosimilar Approvals
- Big Molecule WatchSeptember 25, 2023
FDA Releases Draft Labeling Guidance for Biosimilar Products
- Life Sciences PerspectivesSeptember 25, 2023
Is it Biosimilar or Interchangeable? It Won’t Be Easy to Tell Under FDA’s Latest Draft Labeling Guidance
- Big Molecule WatchSeptember 22, 2023
Update on mRNA Vaccine Patent Litigation
- Life Sciences PerspectivesSeptember 15, 2023
Modernizing the FDA’s 510(k) Program for Medical Devices: Selection of Predicate Devices and Use of Clinical Data in 510(k) Submissions
- Big Molecule WatchSeptember 15, 2023
Generic and Biosimilar Drugs Save $408B For America’s Patients and Healthcare System in 2022
- Life Sciences PerspectivesSeptember 15, 2023
UK’s Medicines Regulator Announces Guidance on the New International Recognition Procedure for the Approval of New Medicines from 1 January 2024
- AlertSeptember 15, 2023
Modernizing the FDA’s 510(k) Program for Medical Devices: Selection of Predicate Devices and Use of Clinical Data in 510(k) Submissions
- Press ReleaseSeptember 27, 2023
Acino Significantly Expands Presence and Capabilities in Latin America Through Acquisition of M8 Pharmaceuticals
- Awards and RankingsSeptember 25, 2023
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Twelfth Consecutive Year
- Press ReleaseSeptember 22, 2023
Aditum Bio Announces Formation of Celexor Bio, Focused on Cell Depletion of Pathologic Cells in Autoimmune and Inflammatory Disorders
- Press ReleaseSeptember 22, 2023
Orionis Biosciences Announces Collaboration with Genentech to Discover and Develop Molecular Glue Class Medicines
- In the PressSeptember 20, 2023
Bloomberg Intelligence Podcast (Bloomberg)
- WebinarSeptember 19, 2023
Legal Challenges to the Inflation Reduction Act: An Update on Pending Challenges and Reactions to Oral Argument in Dayton Area Chamber Of Commerce et al. v. Becerra et al.
- Press ReleaseSeptember 14, 2023
Generate:Biomedicines Completes $273 Million Series C
- Press ReleaseSeptember 13, 2023
Lauxera Capital Partners Invests €17 Million in BioLamina